A generic pharmaceutical manufacturer recalled select lots of a common blood pressure medication after detecting a nitrosamine impurity above allowable limits.
Patients are advised not to stop treatment abruptly and should consult pharmacists about substitutes.
Distribution covered major retail chains and mail-order pharmacies across the country.
